• GSK126: From PRC2 Silencing to FMR1 Reactivation

  2026-08-17

  Explore how GSK126, a selective EZH2 inhibitor, connects PRC2 biology in cancer with FMR1 reactivation in fragile X syndrome models. This article translates the latest neuronal evidence into practical assay decisions without confusing tool-compound data with therapeutic proof.

• Dietary Arachidonic Acid Enhances Humoral Immunity

  2026-08-17

  The reference study shows that dietary arachidonic acid can accelerate vaccine-induced neutralizing antibody production and improve protection against lethal rabies virus infection in mice. Evidence from human volunteers and mechanistic analysis links this effect to lymph-node arachidonic acid metabolism, prostaglandin I2 signaling, and activation of germinal-center B-cell functions.

• HyperFluor™ 594 Goat Anti-Rabbit IgG (H+L) Antibody

  2026-08-16

  A scenario-based guide to using HyperFluor™ 594 Goat Anti-Rabbit IgG (H+L) Antibody, SKU K3305, for reproducible immunofluorescence, tissue staining, flow cytometry, and orthogonal analysis of viability or cytotoxicity assays. It covers wavelength selection, multiplex controls, dilution, storage, interpretation, and practical vendor evaluation.

• H 89 2HCl: A Causal Map of cAMP/PKA Signaling

  2026-08-15

  H 89 2HCl enables mechanistic cAMP-dependent protein kinase inhibition while revealing the interpretive limits of pharmacological pathway tools. This article connects its biochemical profile to dopamine-regulated osteoclastogenesis and presents an assay strategy for separating PKA activity, cAMP abundance, and downstream phosphorylation.

• Deferasirox Review: Innovation, Evidence, and Limits

  2026-08-14

  The 2007 formulary review of deferasirox evaluated its pharmacology, clinical efficacy, tolerability, and economic relevance as an oral alternative to parenteral deferoxamine for transfusional iron overload. Its central contribution was to connect the iron chelation mechanism with comparative clinical evidence and treatment adherence, while highlighting important limits in generalizing results across diseases and tissue iron compartments.

• Apicidin Workflows for HDAC and Toxicology Research

  2026-08-14

  Apicidin combines a strong HDAC3 preference with practical value in cancer, epigenetics, parasite, and reproductive-toxicity assays. This guide translates its mechanism into dose-response, acetylation, meiotic-apparatus, and troubleshooting workflows.

• Cl-Amidine: PAD4 Logic for Translational AML

  2026-08-13

  Cl-Amidine and the Cl-Amidine trifluoroacetate salt offer a practical way to test whether PAD4-dependent histone citrullination intersects with the LMO2–LDB1 transcriptional program in AML, while preserving a clear boundary between mechanistic hypothesis and validated evidence.

• In-Frame sspA Deletion Simplifies Bitespiramycin

  2026-08-13

  The reference study engineered Streptomyces spiramyceticus WSJ-2 by partially deleting the 3-O-acyltransferase gene sspA, preventing formation of two major bitespiramycin derivatives. This strain-engineering strategy reduced product complexity and provides a practical framework for improving compositional control in macrolide antibiotic biosynthesis.

• Hoechst 33258: Bis-Benzimide DNA Stain

  2026-08-12

  Hoechst 33258 is a cell-permeable bis-benzimide DNA stain that binds AT-rich minor-groove sites and produces blue fluorescence. Its 350 nm excitation and approximately 461 nm emission support DNA visualization, live-cell imaging, flow cytometry, and cell cycle analysis when dye efflux and phototoxicity are controlled.

• D-Luciferin Sodium Salt for CAR-M Imaging

  2026-08-12

  D-Luciferin sodium salt converts firefly luciferase expression into a practical, longitudinal readout for tumor burden, reporter stability, and cellular energy status. This workflow connects ATP-dependent bioluminescence with CAR-macrophage immunotherapy research while separating true biological effects from substrate, oxygen, and delivery artifacts.

• Calcitriol Workflows for Bone Homeostasis Research

  2026-08-11

  Build stronger bone, immune, and signaling assays with Calcitriol, the direct VDR-active metabolite of vitamin D3. This guide translates NFIA-centered bone biology into practical dose-response, differentiation, cytokine, and Hedgehog pathway workflows while highlighting controls and troubleshooting decisions.

• Adefovir Pharmacokinetics in OAT1 Cocktail Phenotyping

  2026-08-11

  The 2024 reference study used population pharmacokinetic modeling to explain why adefovir exposure increased modestly in a transporter cocktail without evidence of altered renal OAT1 elimination. Its results refine the interpretation of adefovir renal clearance as a phenotyping metric and distinguish absorption or prodrug-conversion effects from transporter-mediated drug interactions.

• SmD2 Acetylation Links Splicing to PARP Sensitivity

  2026-08-10

  This 2024 Nature Communications study identifies SmD2 acetylation as a regulatory connection between core spliceosome activity, BRCA1/FANC cassette exons, and PARP inhibitor sensitivity in hepatocellular carcinoma. Its findings support combining HDAC inhibition with PARP blockade as a strategy for HCC models with impaired DNA repair.

• Mouse Neutrophil Cell Isolation Kit for Assays

  2026-08-09

  The Mouse Neutrophil Cell Isolation Kit supports high-purity, low-perturbation neutrophil preparation from mouse tissues. This guide explains how negative selection can improve assay interpretation in functional immunology and neutrophil-targeted nanovaccine studies.

• TAK-715 and the Next Logic of p38α Inhibition

  2026-08-08

  TAK-715 offers translational researchers a selective way to interrogate p38α biology, while emerging kinase–phosphatase insights suggest a more rigorous framework for connecting target engagement with durable anti-inflammatory responses.

16520 records 1/1102 page Next 12345 下5页 Last page